The clinical content of preconception care: women with psychiatric conditions

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 6 SUPPL. B, 2008, Pages

  Frieder, Ariela ^a   Dunlop, Anne L ^b   Culpepper, Larry ^c   Bernstein, Peter S ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

anxiety; bipolar; depression; preconception; schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CHLORPROMAZINE; FOLIC ACID; HALOPERIDOL; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; PAROXETINE; PERPHENAZINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE; VALPROIC ACID; VENLAFAXINE;

ANENCEPHALUS; ANXIETY DISORDER; BIPOLAR DISORDER; CARDIOVASCULAR MALFORMATION; CLEFT FACE; COGNITIVE THERAPY; CRANIOFACIAL MALFORMATION; CRANIOFACIAL SYNOSTOSIS; DEPRESSION; DIABETES MELLITUS; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEEDING DISORDER; FETUS MALFORMATION; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; JAUNDICE; LOW BIRTH WEIGHT; MATERNAL CARE; MICROCEPHALY; MONOTHERAPY; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEURAL TUBE DEFECT; OBESITY; OMPHALOCELE; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; PUERPERIUM; PULMONARY HYPERTENSION; REVIEW; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SUBSTANCE ABUSE; TREATMENT DURATION; VITAMIN SUPPLEMENTATION;

ANXIETY DISORDERS; BIPOLAR DISORDER; DEPRESSIVE DISORDER; FEMALE; HUMANS; MATERNAL WELFARE; MENTAL DISORDERS; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; SCHIZOPHRENIA;

EID: 57149100559     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.09.001     Document Type: Review

References (44)

1. Burt V.K., and Hendrick V.C. Clinical manual of women's mental health. In: Wyszynski A.A., and Wyszynski B. (Eds). Manual of psychiatric care for the medically ill (2005), American Psychiatric Publishing, Inc, Arlington, VA
2. Cohen L.S., and Nonacs R.M. Mood and anxiety disorders during pregnancy and postpartum. Review of psychiatry, volume 24. In: Wyszynski A.A., and Wyszynski B. (Eds). Manual of psychiatric care for the medically ill (2005), American Psychiatric Publishing, Inc, Arlington, VA
3. Brockington I. Motherhood and mental health (1996), Oxford University Press, New York, NY
4. Wyszynski A.A., and Lusskin S. The obstetric patient. In: Wyszynski A.A., and Wyszynski B. (Eds). Manual of psychiatric care for the medically ill (2005), American Psychiatric Publishing, Inc, Arlington, VA
5. Ross L.E., and McLean L.M. Anxiety disorders during pregnancy and the postpartum period: a systematic review. J Clin Psychiatry 67 (2006) 8
6. Halbreich U. The association between pregnancy processes, preterm delivery, low birth weight and postpartum depression-the need for interdisciplinary integration. Am J Obstet Gynecol 193 (2005) 1312-1322
7. Brockington I. Postpartum psychiatric disorders. Lancet 363 (2004) 303-310
8. Davis E.P., Glynn L.M., Schetter C.D., Hobel C., Chicz-Demet A., and Sandman C.A. Prenatal exposure to maternal depression and cortisol influences infant temperament. J Am Acad Child Adolesc Psychiatry 46 (2007) 737-746
9. Talge N.M., Neal C., and Glover V. Early Stress, Translational Research and Prevention Science Network: fetal and Neonatal Experience on child and Adolescent Mental Health. Antenatal maternal stress and long term effects on child neurodevelopment: how and why?. J Child Psychol Psychiatry 48 (2007) 245-261
10. Bloch M., Rotenberg N., Koren D., and Klein E. Risk factors for early postpartum depressive symptoms. Gen Hosp Psychiatry 28 (2006) 1-2
11. Robertson E., Grace S., Wallington T., and Stewart D.E. Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry 26 (2004) 289-295
12. Monk C. Stress and mood disorders during pregnancy: implications for child development. Psychiatric Quarterly 72 (2001) 347-357
13. Davis E.P., Snidman N., Wadhwa P.D., Glynn L.M., Schetter C.D., and Sandman C.A. Prenatal maternal anxiety and depression predict negative behavioral reactivity in infancy. Infancy 6 (2004) 319-331
14. Brockington I.F., Macdonald E., and Wainscott G. Anxiety, obsessions and morbid preoccupations in pregnancy and the puerperium. Arch Womens Ment Health 9 (2006) 253-263
15. Loveland Cook C.A., Flick L.H., Homan S.M., Campbell C., McSweeney M., and Gallagher M.E. Posttraumatic stress disorder in pregnancy: prevalence, risk factors, and treatment. Obstet Gynecol 103 (2004) 710-717
16. Diagnostic and statistical manual of mental disorders. Text revision. Fourth edition (2000), American Psychiatric Association, Arlington, VA
17. Robertson E., Grace S., Wallington T., and Stewart D.E. Antenatal risk factors for postpartum depression: a synthesis of recent literature. Gen Hosp Psychiatry 26 (2004) 289-295
18. Schulberg H.C., Raue P.J., and Rollman B.L. The effectiveness of psychotherapy in treating depressive disorders in primary care practice: clinical and cost perspectives. Gen Hosp Psychiatry 24 (2002) 203-212
19. Miller L.J. Use of electroconvulsive therapy during pregnancy. Hosp Community Psychiatry 45 (1994) 444-450 (Level III)
20. Rabheru K. The use of elelctroconvulsive therapy in special patient populations. Can J Psychiatry 46 (2001) 710-719 (Level III)
21. Andrade S.E., Raebel M.A., Brown J., et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 198 (2008) 191.e1-191.e5
22. Altshuler L.L., Cohen L.S., Szuba M.P., Burt V.K., Fitlin M., and Mintz J. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 153 (1996) 392-606
23. Wisner K.L., Gelenberg A.J., Leonard H., Zarin D., and Frank E. Pharmacologic treatment of depression during pregnancy. JAMA 282 (1999) 1264-1269
24. Alwan S., Reefhuis J., Rasmussen S.A., Olney R.S., and Friedman J.M. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356 (2007) 2684-2692
25. Louik C., Lin A.E., Werler M.M., Hernández-Díaz S., and Mitchell A.A. First-trimester use of selective serotonin reuptake inhibitors and the risk of birth defects. N Engl J Med 356 (2007) 2675-2683
26. Oberlander T.F., Warburton W., Misri S., Aghajanian J., and Hertzman C. Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data. Arch Gen Psychiatry 64 (2006) 898-906
27. Suri R., Altshuler L., Hellemann G., Burt V.K., Aquino A., and Mintz J. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 164 (2007) 1206-1213
28. Chambers C.D., Hernandez-Diaz S., VanMarter L.J., et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354 (2006) 579-587
29. Kahn D. Moline ML, Ross RW, Cohen LS, Altshuler LL. Major depression during conception and pregnancy: a guide for patients and families. Expert Consensus Guideline Series. March 2001.
30. Freeman M.P. Antenatal depression: navigating the treatment dilemmas. Am J Psychiatry 164 (2007) 1162-1165
31. Cohen L.S., Nanacs R.M., Bailey J.W., et al. Relapse of depression during pregnancy following antidepressant discontinuation: a preliminary prospective study. Arch Womens Ment Health 7 (2004) 217-221
32. Viguera A.C., Cohen L.S., Bouffard S., Whitfield T.H., and Baldessarini R.J. Reproductive decisions by women with bipolar disorder after pre pregnancy psychiatric consultation. Am J Psychiatry 159 (2002) 2102-2104
33. Merikangas K.R., and Low N.C. The epidemiology of mood disorders. Curr Psychiatry Rep 6 (2004) 411-421
34. Yonkers K.A., Wisner K.L., Stowe Z., et al. Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 161 (2004) 608-620
35. Viguera A.C., Whitfield T., Baldessarini R.J., et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 164 (2007) 1817-1824
36. Stewart D.E., Klompenhouwer J.L., Kendell R.E., and Van Hulst A.M. Prophylactic lithium in puerperal psychosis. The experience of three centers. Br J Psychiatry 158 (1991) 393-397
37. Cohen L.S. Treatment of bipolar disorder during pregnancy. J Clin Psychiatry 68 suppl 9 (2007) 4-9
38. Shor S., Koren G., and Nulman I. Teratogenicity of lamotrigine. Can Fam Physician 53 (2007) 1007-1009
39. Viguera A.C., Koukopoulos A., Muzina D.J., and Baldessarini R.J. Teratogenicity and anticonvulsants: lessons from neurology to psychiatry. J Clin Psychiatry 68 suppl 9 (2007) 29-33
40. Jones I., and Craddock N. Bipolar disorder and childbirth: the importance of recognizing risk. Br J Psychiatry 186 (2005) 453-454
41. Viguera A.C., Cohen L.S., Baldessarini R.J., and Nonacs R. Managing bipolar disorder during pregnancy: weighing the risks and benefits. Can J Psychiatry 47 (2002) 426-436
42. Gentil S. Prophylactic treatment of bipolar disorder in pregnancy and breastfeeding: focus on emerging mood stabilizers. Bipolar Disorders 8 (2006) 207-220
43. Yaeger D., Smith H.G., and Altshuler L.L. Atypical antipsychotics in the treatment of schizophrenia during pregnancy and postpartum. Am J Psychiatry 163 (2006) 2064-2070
44. Patton S.W., Misri S., and Corral M.R. Antipsychotic medication during pregnancy and lactation in women with schizophrenia: evaluating the risk. Can J Psychiatry 47 (2002) 959-965